An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive women

International Journal of Gynecological Cancer

Volumn 19, Issue 4, 2009, Pages 728-733

  Gage, Julia C ^a   Rodriguez, Ana Cecilia ^b   Schiffman, Mark ^a   Adadevoh, Sydney ^c   Larraondo, Manuel J Alvarez ^d   Chumworathayi, Bandit ^e   Lejarza, Sandra Vargas ^f   Araya, Luis Villegas ^f   Garcia, Francisco ^g   Budihas, Scott R ^h   Long, Rodney ^h   Katki, Hormuzd A ^a   Herrero, Rolando ^b   Burk, Robert D ⁱ   Jeronimo, Jose ^j  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Proyecto Epidemiologico Guanacaste   (Costa Rica)

^c ReproHealth Consult   (Ghana)

^d INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

^e KHON KAEN UNIVERSITY   (Thailand)

^f CAJA COSTARRICENSE DE SEGURO SOCIAL   (Costa Rica)

^g UNIVERSITY OF ARIZONA   (United States)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^j Appropriate Technology in Health   (United States)

more..

Author keywords

Cervical intraepithelial neoplasia; Cryotherapy; Human papillomavirus; Low resource settings; Screen and treat

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PREVENTION; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; CRYOTHERAPY; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; GYNECOLOGY; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MIDWIFE; OUTCOME ASSESSMENT; PATIENT REFERRAL; PERFORMANCE; PRECANCER; PRIORITY JOURNAL; THERAPY EFFECT; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; WART VIRUS;

ADULT; CRYOTHERAPY; FEMALE; GYNECOLOGY; HUMANS; MIDDLE AGED; MIDWIFERY; PAPILLOMAVIRUS INFECTIONS; TRIAGE; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS;

EID: 67651008731     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a48b99     Document Type: Article

References (20)

1. Qiao Y, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008;9:929-936.
2. Denny L, Kuhn L, De Souza M, et al. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA. 2005;294:2173-2181.
3. Gage J, Rodriguez AC, Schiffman M, et al. Evaluation of treatability by cryotherapy of HPV positive women. J Low Genit Tract Dis. 2009. In press.
4. Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, et al. Management of cryotherapy-ineligible woman in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol. 2008;110:402-407.
5. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Lancet. 1999;353:869-873.
6. Belinson JL, Pretorius RG, Zhang WH, et al. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol. 2001;98:441-444.
7. Sangwa-Lugoma G, Mahmud S, Nasr SH, et al. Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. Int J Cancer. 2006;119:1389-1395.
8. Gage JC, Hanson VW, Abbey K, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol. 2006;108:264-272.
9. Sankaranarayanan R, Shastri SS, Basu P, et al. The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia. Cancer Detect Prev. 2004;28:345-351.
10. Winkler JL, Lewis K, Del Aguila R, et al. Is magnification necessary to confirm visual inspection of cervical abnormalities? A randomized trial in Peru. Rev Panam Salud Publica. 2008;23:1-6.
11. Massad LS, Jeronimo J, Katki H, et al. The accuracy of colposcopic grading for detection of high grade cervical intraepithelial neoplasia. Obstet Gynecol. J Low Genit Tract Dis. In press.
12. Castle PE, Schiffman M, Gravitt PE, et al. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol. 2002;68: 417-423.
13. Bratti MC, Rodriguez AC, Schiffman M, et al. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica. Rev Panam Salud Publica. 2004;15:75-89.
14. Herrero R, Schiffman MH, Bratti C, et al. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica. 1997;1:362-375.
15. Almonte M, Ferreccio C, Winkler JL, et al. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer. 2007;121:796-802.
16. Jeronimo J, Long LR, Neve L, et al. Digital tools for collecting data from Cervigrams for research and training in colposcopy. J Low Genit Tract Dis. 2006;10:16-25.
17. Jeronimo J, Long R, Neve L, et al. Preparing digitized Cervigrams for colposcopy research and education: determination of optimal resolution and compression parameters. J Low Genit Tract Dis. 2006;10:39-44.
18. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
19. Gage JC, Ferreccio C, Gonzales M, et al. Follow-up care of women with an abnormal cytology in a low-resource setting. Cancer Detect Prev. 2003;27:466-471.
20. Rodríguez AC, Schiffman M, Herrero R, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst. 2008;100:513-517.